3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
4
Squamous Cell Carcinoma of Head and Neck
3
Sarcoma, Ewing
2
Sarcoma
2
Rhabdomyosarcoma
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neuroblastoma
2
Carcinoma, Renal Cell
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Sarcoma, Clear Cell
1
Rhabdoid Tumor
1
Pancreatic Adenocarcinoma
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Neuroectodermal Tumors, Primitive
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Meningioma
1
Melanoma
1
Medulloblastoma
1
Malignant Liver Neoplasm
1
Lung Neoplasms
1
Kidney Neoplasms
1
Head and Neck Neoplasms
1
Glioma
1
Ependymoma
1
Craniopharyngioma
1
Choroid Plexus Neoplasms
1
Interventions
Trastuzumab
243
Paclitaxel
193
Cyclophosphamide
158
Docetaxel
134
Letrozole
113
Capecitabine
113
Fulvestrant
106
Doxorubicin
103
Bevacizumab
87
Carboplatin
81
exemestane
80
Anastrozole
79
Lapatinib
70
Tamoxifen
69
Albumin-Bound Paclitaxel
57
palbociclib
54
pertuzumab
53
Taxes
51
Gemcitabine
50
Radiotherapy
46
eribulin
43
pembrolizumab
41
Everolimus
41
Ado-Trastuzumab Emtansine
41
Vinorelbine
38
130-nm albumin-bound paclitaxel
35
ixabepilone
32
Epirubicin
28
pegfilgrastim
25
liposomal doxorubicin
25
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Breast Neoplasms
×
Radiotherapy, Image-Guided
×
Clear all
No trials found.